In the post pandemic era, Gentech helps the rise of the pharmaceutical market in Mengguo

The project team of 5 people from Shanghai Zhengfan Technology Co., Ltd. ("Zhengfan Technology") has arrived in Dhaka. They are the first batch of personnel from Zhengfan to go to Bangladesh in 2021 to carry out the Renata and IBN SINA pharmaceutical plant projects for a period of three months.

Bangladesh has a population of 200 million, and the pharmaceutical industry is the country's second largest source of tax revenue after the clothing industry. It is one of the rapidly growing industries and plays an important role in the economy. Mengguo has over 200 pharmaceutical factories, providing 97% of the total drug demand in the local market, and exporting drugs to global markets including Europe, forming fierce competition with neighboring generic drug country India.

Zhengfan Technology entered the pharmaceutical market in Bangladesh in 2015 and has served several top ten pharmaceutical companies such as ACME over the past five years, steadily improving its market reputation. In order to uphold contracts and keep promises, Zhengfan overcame the severe challenges of the current international epidemic, selected a capable team, vaccinated all personnel with the national medicine vaccine and received strengthened training, equipped with sufficient epidemic prevention materials, and implemented fully enclosed management with the support of local agents to ensure the safety of personnel in epidemic prevention.

They are real warriors of Zhengfan Technology, and also representatives of a strong and confident country going to the "the Belt and Road"! Wishing them a smooth execution of their mission and a safe return home soon!